Skip to main content
. 2022 Oct 31;9:1027758. doi: 10.3389/fmed.2022.1027758

FIGURE 3.

FIGURE 3

The prognostic values of hsa-miR-200a-3p and hsa-let-7c-5p, as programmed death-ligand 1 (PD-L1)-inhibiting miRs, based on TCGA-LUAD and TCGA-LUSC databases. (A) High expression of hsa-miR-200a-3p is associated with enhanced disease-specific survival of LUAD patients. (B) High expression of hsa-let-7c-5p is associated with improved disease-specific survival of patients with lung squamous cell carcinoma (LUSC).